Pancreatitis Trial, Recruiting NCT05197920 Sponsor: Milton S. Hershey Medical Center Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT05197920
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with acute pancreatitis (a sudden inflammation of the pancreas) within the last 90 days before joining the study
  • You are able to fully take part in all parts of the study, including signing a consent form, completing questionnaires, taking part in phone interviews, undergoing metabolic tests, and attending follow-up visits over time

Who may not be able to join:

  • You have already been diagnosed with definite chronic (long-term) pancreatitis, shown by calcium deposits or certain blockages in the pancreas seen on a CT scan, MRI, or related imaging
  • Your acute pancreatitis was caused by a specific medical procedure (ERCP) and you were only in the hospital for less than 48 hours because of it
  • You have already had a surgical or tube-based procedure to remove or drain dead tissue from your pancreas before joining the study
  • You have a tumor of the pancreas, including cancer, hormone-producing tumors, or cancer that has spread to the pancreas
  • You have a confirmed or suspected fluid-filled growth (cyst) on the pancreas that is linked to a widened pancreatic duct, or is thought to have caused your pancreatitis (confirm with trial site)
  • You have previously had surgery on your pancreas, such as removal of part or all of it
  • You are taking certain medications that are not allowed by the study within 30 days before joining (confirm with trial site for the full list)
  • You have a serious ongoing illness that could affect the study results or put you at extra risk, including: a history of organ transplant, AIDS, active cancer treatment within the past 12 months (except certain minor skin cancers), severely reduced kidney function or being on dialysis, severe liver scarring (cirrhosis), or any condition where life expectancy is less than 12 months
  • You are known to be pregnant at the time of joining the study (note: if you become pregnant during the study, you may be able to continue with some adjustments)
  • You are currently incarcerated
  • You have any other condition or situation that the research team believes could affect your safety or the reliability of the study results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vernon M Chinchilli, PhD, Penn State College of Medicine

Phone: 717-531-1258

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Milton S. Hershey Medical Center
Registry
ClinicalTrials.gov
Start date
14 January 2022
Est. completion
31 January 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

diabetes mellitus (DM) following a qualifying episode of acute pancreatitis (AP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov